References
- Hines PA, Guy RH, Humphreys AJ, Papaluca-Amati M. The European Medicines Agency's goals for regulatory science to 2025. Nat Rev Drug Discov 2019;18(6):403-4. https://doi.org/10.1038/d41573-019-00071-2
- Sakuma I. Education and training in regulatory science for medical device development. Annu Int Conf IEEE Eng Med Biol Soc 2013:3155-8.
- Hines PA, Guy RH, Brand A, Humphreys AJ, Papaluca-Amati M. Regulatory science and innovation programme for Europe (ReScIPE): A proposed model. Br J Clin Pharmacol 2020;86(12):2530-4. https://doi.org/10.1111/bcp.14099
- Honig P, Zhang L. Regulation and innovation: Role of regulatory science in facilitating pharmaceutical innovation. Clin Pharmacol Ther 2019;105(4):778-81. https://doi.org/10.1002/cpt.1367
- Donnelly F. Regulatory science as a means to respond to EU healthcare challenges and global market meeds. Journal of Regulatory Science. 2016;4:21-8.
- Institute of Medicine. Strengthening a workforce for innovative regulatory science in therapeutics development: workshop summary. Washington (DC): National Academies Press, 2012:31-41.
- Meyer RJ. The role of academic medical centers in advancing regulatory science. Clin Pharmacol Ther 2014;95(5):471-3. https://doi.org/10.1038/clpt.2014.33
- Duke-NUS medical school. Center of regulatory excellence. Available from https://www.duke-nus.edu.sg/core. Accessed September 9, 2021.
- European Medicines Agency. Road map to 2015. Available from https://www.ema.europa.eu/en/documents/report/road-map-2015-european-medicines-agencys-contribution-science-medicineshealth_en.pdf2010. Accessed September 9, 2021.
- Gaspar R, Aksu B, Cuine A, Danhof M, Takac MJ-M, Linden HH, et al. Towards a European strategy for medicines research (2014-2020): The EUFEPS position paper on Horizon 2020. Eur J Pharm Sci 2012;47(5):979-87. https://doi.org/10.1016/j.ejps.2012.09.020
- Horizon 2020. Nat Mater. 2012;11(6):477. https://doi.org/10.1038/nmat3353
- Laverty H, Meulien P. The innovative medicines initiative -10 years of public-private collaboration. Front Med (Lausanne) 2019;6:275. https://doi.org/10.3389/fmed.2019.00275
- European Medicines Agency. EMA regualtory science to 2025 strategic reflection. Available from https://www.ema.europa.eu/en/documents/regulatory-procedural-guideline/ema-regulatoryscience-2025-strategic-reflection_en.pdf. Accessed September 9, 2021.
- Goldman M, Wittelsberger A, De Magistris MT. The innovative medicines initiative moves translational immunology forward. Eur J Immunol 2013;43(2):298-302. https://doi.org/10.1002/eji.201370024
- Goldman M. The innovative medicines initiative: a European response to the innovation challenge. Clin Pharmacol Ther 2012;91(3):418-25. https://doi.org/10.1038/clpt.2011.321
- Goldman M, Seigneuret N, Eichler HG. The innovative medicines initiative: an engine for regulatory science. Nat Rev Drug Discov 2015;14(1):1-2. https://doi.org/10.1038/nrd4520
- Spindler P, Bach KF, Schmiegelow M, Bedlington N, Eichler HG. Innovation of medical products: The evolution of regulatory science, research, and education. Ther Innov Regul Sci 2016;50(1):44-8. https://doi.org/10.1177/2168479015599810
- Innovative Medicines Initiative website. Available from https://www.imi.europa.eu/. Accessed September 9, 2021.
- Dance A. Regulatory science: Researchers in the pipeline. Nature 2013;496(7445):387-9. https://doi.org/10.1038/nj7445-387a
- Innovative Medicines Initiative. Report from the IMI-EMA-FDA regulatory science summit-collaborative research through publicprivate partnership in support to advancing regulatory science. Available from https://www.imi.europa.eu/sites/default/files/uploads/documents/reference-documents/RegulatorySummit2019_report.pdf Accessed September 9, 2021.
- Payton A, Janko C, Renn O, Hardman M; EMTRAIN Consortium. On-course(®) portal: a tool for in-service training and career development for biomedical scientists. Drug Discov Today 2013; 18(17-18):803-6. https://doi.org/10.1016/j.drudis.2013.04.004
- IMI EMTRAIN website. Available from https://www.imi.europa.eu/projects-results/project-factsheets-/emtrain. Accessed September 9, 2021.
- Payton A, Dallakian P, Fitton A, Payton A, Hardman M, Yuille M. Course fees and academic ranking: insights from the IMI EMTRAIN on-course® database. Drug Discov Today 2014;19(7):830-3. https://doi.org/10.1016/j.drudis.2013.12.001
- Hardman M, Brooksbank C, Johnson C, et al. LifeTrain: towards a European framework for continuing professional development in biomedical sciences. Nat Rev Drug Discov 2013;12(6):407-8. https://doi.org/10.1038/nrd4026
- LifeTrain website. Available from https://www.lifetrain.eu/. Accessed September 9, 2021.
- Klech H, Brooksbank C, Price S, et al. European initiative towards quality standards in education and training for discovery, development and use of medicines. Eur J Pharm Sci 2012;45(5):515-20. https://doi.org/10.1016/j.ejps.2011.12.005
- SafeSciMET website. Available from https://ssm.afww.unikonstanz.de/. Accessed September 9, 2021.
- Eu2P website. Available from https://eu2p.org/. Accessed September 9, 2021.
- Boeynaems JM, Canivet C, Chan A, et al. A European approach to clinical investigator training. Front Pharmacol 2013;4:112. https://doi.org/10.3389/fphar.2013.00112
- PharmaTrain website. Available from https://pharmatrain.eu/. Accesssed September 9, 2021.
- Silva H, Stonier P, Buhler F, et al. Core competencies for pharmaceutical physicians and drug development scientists. Front Pharmacol 2013;4:105. https://doi.org/10.3389/fphar.2013.00105
- Kerpel-Fronius S, Rosenkranz B, Allen E, et al. Education and training for medicines development, regulation, and clinical research in emerging countries. Front Pharmacol 2015;6:80. https://doi.org/10.3389/fphar.2015.00080
- Silva H, Buhler F, Maillet B, et al. Continuing medical education and professional development in the European Union. Pharm Med 2012;26(4):223-33. https://doi.org/10.1007/BF03262479
- Bongiovanni S, Purdue R, Kornienko O, Bernard R. Quality in non-GXP research environment. In: Bespalov A, Michel M, Steckler T eds. Good research practice in non-clinical pharmacology and biomedicine. Handbook of Experimental Pharmacology, Cham: Springer Open, vol 257, 2020:1-17. https://doi.org/10.1007/164_2019_274. Accessed September 9, 2021
- EQIPD website. Available from https://quality-preclinical-data.eu/. Accessed September 9, 2021.
- Bespalov A, Bernard R, Gilis A, et al. Introduction to the EQIPD quality system. Elife. 2021;10:e63294. https://doi.org/10.7554/eLife.63294
- Ministry of Food and Drug Safety. Regulatory science talent training project (R&D) announcement. 2021. Available from https://www.mfds.go.kr/brd/m_99/view.do?seq=44172. Accessed September 9, 2021